Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Howl is a creative platform that provides commerce and payment tech providing better rates and easy payments for big ideas.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Modyfi is an image editor that provides designers with AI-native design, tools, and real-time collaboration.
Functional Finance is a fintech platform that enables insurance operators to manage billing, financing, and other aspects of money transfer.
In-House Health is an AI-powered technical platform for modern nursing teams.
Beehiiv is an email newsletter platform enhancing audience engagement, growth, and monetization.
SafeBase is a trust center platform for friction-free security reviews changing how companies communicate their security and trust posture.
ARRIS develops an additive molding technology for manufacturing 3D-aligned continuous fiber thermoplastic composite parts at scale.
AISquared is a SaaS that provides AI model integration, real-time insights, data analytics, and optimization services.
Habitat Health provides health and social care to older persons with medical services.
Mithril is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources.
Inkitt is building the Disney of the 21st century: using AI to find unknown stories and turning them into blockbusters (novels and TV shows)
Our purpose is to make every pregnancy around the world safer.
Topia is a talent mobility platform that enables companies to effectively deploy, oversee, and engage their employees globally.
Gravel is a technology company that makes it simple for you to find qualified and trustworthy construction workers.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Ozone develops an AI-powered video editing platform that allows users to collaborate remotely.
Teal Drones is a commercial and government unmanned aerial vehicle technology.
Xpressbees is a logistics company that offers customized express delivery services.
Our Modern AI platform enables anyone to build production-ready AI apps in a few clicks.
New Enterprise Associates has invested in 641 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Health Care, Artificial Intelligence (AI), Biotechnology, Medical, Therapeutics. The firm invests across 57 different industry categories.
Among tracked funding rounds, Cardurion Pharmaceuticals received $260.0M in a Series B round. New Enterprise Associates's total known invested capital is $35.5B.
New Enterprise Associates's average investment size is $69.0M across its portfolio of 641 companies.
Recent New Enterprise Associates portfolio additions include MBX Biosciences, Howl, Brenig Therapeutics, Magenta Medical, Cardurion Pharmaceuticals. These companies were founded in 2020 or later.